Opus Genetics, Inc.

Opus Genetics, Inc.verified

IRD

Price:

$2.23

Market Cap:

$153.73M

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for reti...[Read more]

Industry

Biotechnology

IPO Date

2015-01-19

Stock Exchange

NASDAQ

Ticker

IRD

The ROE as of December 2025 (TTM) for Opus Genetics, Inc. (IRD) is -366.68%

According to Opus Genetics, Inc.’s latest financial reports and current stock price. The company's current ROE is -366.68%. This represents a change of 95.97% compared to the average of -187.12% of the last 4 quarters.

Opus Genetics, Inc. (IRD) Historical ROE (quarterly & annually)

How has IRD ROE performed in the past?

The mean historical ROE of Opus Genetics, Inc. over the last ten years is -137.94%. The current -366.68% ROE has changed 165.82% with respect to the historical average. Over the past ten years (40 quarters), IRD's ROE was at its highest in in the December 2020 quarter at 138.71%. The ROE was at its lowest in in the December 2024 quarter at -522.53%.

Quarterly (TTM)
Annual

Average

-137.94%

Median

9.34%

Minimum

-855.62%

Maximum

182.82%

Opus Genetics, Inc. (IRD) ROE by Quarter and Year

Discovering the peaks and valleys of Opus Genetics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.18%

Maximum Annual ROE = 182.82%

Minimum Annual Increase = -239.55%

Minimum Annual ROE = -855.62%

Quarterly (TTM)
Annual
YearROEChange
2024-855.62%4.18%
2023-20.01%-151.72%
202238.69%-115.16%
2021-255.12%-239.55%
2020182.82%124.04%

Opus Genetics, Inc. (IRD) Average ROE

How has IRD ROE performed in the past?

The current ROE of Opus Genetics, Inc. (IRD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-278.98%

5-year avg

-181.85%

10-year avg

-137.94%

Opus Genetics, Inc. (IRD) ROE vs. Peers

How is IRD’s ROE compared to its peers?

Opus Genetics, Inc.’s ROE is greater than Acumen Pharmaceuticals, Inc. (-97.41%), greater than Seer, Inc. (-26.48%), less than Agenus Inc. (59.64%), greater than Inovio Pharmaceuticals, Inc. (-80970.00%), greater than VistaGen Therapeutics, Inc. (-90.65%), greater than TuHURA Biosciences, Inc. (-393.18%), greater than Alector, Inc. (-123.02%), greater than Cognition Therapeutics, Inc. (-251.23%), greater than Instil Bio, Inc. (-54.32%), less than Seres Therapeutics, Inc. (15.31%),

Build a custom stock screener for Opus Genetics, Inc. (IRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opus Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opus Genetics, Inc. (IRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opus Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Opus Genetics, Inc.'s ROE?

How is the ROE calculated for Opus Genetics, Inc. (IRD)?

What is the highest ROE for Opus Genetics, Inc. (IRD)?

What is the 3-year average ROE for Opus Genetics, Inc. (IRD)?

What is the 5-year average ROE for Opus Genetics, Inc. (IRD)?

How does the current ROE for Opus Genetics, Inc. (IRD) compare to its historical average?